SCHEMBL3099103

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3114294	0.89	RBP4 (0.72)	RBP4MEN1KMT2ALMNASYK
	SCHEMBL3094391	0.88	RBP4 (0.61)	RBP4MEN1KMT2ALMNATSHR
	SCHEMBL3105177	0.87	RBP4 (1.00)	RBP4TTR
	SCHEMBL3103421	0.87	RBP4 (1.00)	RBP4MEN1KMT2ALMNA
	SCHEMBL3105427	0.87	RBP4 (0.76)	RBP4MEN1KMT2ATTR
	SCHEMBL3106917	0.85	RBP4 (0.56)	RBP4MEN1KMT2ALMNATTR
	SCHEMBL3104804	0.84	RBP4 (1.00)	RBP4TTR
	SCHEMBL18404236	0.83	RBP4 (0.53)	RBP4MEN1KMT2ALMNATTR
	SCHEMBL3113162	0.82	RBP4 (0.56)	RBP4MEN1KMT2ALMNASYK
	SCHEMBL3103705	0.82	RBP4 (0.60)	RBP4LPAR1LPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.